The Poly ICLC data in addition is kind of the gasoline on the fire and that plus CSF-1 and a checkpoint inhibitor in some cases might be the game over scenario that causes a lot of current efforts to come to a screeching halt. Kind of a “read em and weep” moment for many while a triumph for patients. Best wishes.
Market Data 
Markets 
AI
